Review of First COVID-19 Shot for Youngest Kids Expected to Finish Mid-July: Health Canada

A person draws out Moderna vaccine during a drive through COVID-19 vaccine clinic at St. Lawrence College in Kingston, Ontario, on Jan. 2, 2022. The Canadian Press/Lars Hagberg

Federal health officials are reviewing a submission from Moderna seeking to have its COVID-19 shots approved for children as young as six months old.

In a series of tweets on July 5, Health Canada said they expect to make a decision by mid-July on whether or not to approve Moderna’s Spikevax COVID-19 vaccine for children between the ages of six months and five years old.